# Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors

> **NCT05322512** · NA · UNKNOWN · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 20 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** 18F-FDG

## Key facts

- **NCT ID:** NCT05322512
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-05-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05322512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05322512, "Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05322512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*